Bolt Biotherapeutics BOLT
0.405
0.02
4.71
%
已收盤:03/31 20:00 (臺灣)
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
---|---|---|---|---|---|---|
2024Q4 | 0.54 | 106.15 | -0.41 | -16,916 | -16 | |
2024Q3 | 0.65 | 108.35 | -0.40 | -16,443 | -15 | |
2024Q2 | 0.75 | 106.61 | -0.56 | -22,597 | -21 | |
2024Q1 | 1.40 | 158.10 | -0.28 | -17,092 | -11 | |
2023Q4 | 1.12 | 110.41 | -0.47 | -19,766 | -18 | |
2023Q3 | 1.04 | 111.85 | -0.43 | -18,183 | -16 | |
2023Q2 | 1.28 | 109.83 | -0.48 | -19,832 | -18 | |
2023Q1 | 1.39 | 108.45 | -0.45 | -18,415 | -17 | |
2022Q4 | 1.30 | 105.22 | -0.53 | -21,040 | -20 | |
2022Q3 | 1.48 | 102.70 | -0.58 | -22,346 | -22 | |
2022Q2 | 2.04 | 101.74 | -0.61 | -23,059 | -23 | |
2022Q1 | 2.74 | 100.84 | -0.64 | -23,876 | -24 | |
2021Q4 | 4.90 | 99.70 | -0.73 | -27,075 | -27 | |
2021Q3 | 12.65 | 100.56 | -0.59 | -23,526 | -23 | |
2021Q2 | 15.46 | 100.75 | -0.51 | -23,761 | -24 | |
2021Q1 | 32.91 | 75.35 | -1.14 | -18,426 | -24 | |
2020Q4 | 54.53 | -14.70 | -16,922 | -31 | ||
2020Q3 | -12,405 | -10 | ||||
2020Q2 | -0.79 | -11,110 | -11 | |||
2020Q1 | -0.62 | -8,745 | -9 |